• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

DrFirst, MARQUIS Med Rec Partner to Help Hospitals Improve Patient Safety Through Better Medication Reconciliation

Share:

June 23, 2020

Largely underreported in all care settings, adverse drug events (ADEs) caused by medication discrepancies are estimated to affect as many as 40% of hospitalized patients and up to 17% of patients in the 30 days following discharge. DrFirst and the Society for Hospital Medicine, through its MARQUIS Med Rec Collaborative, announced they will work with hospitals to reduce these discrepancies in the medication reconciliation process—one of the most important steps to improve patient safety during transitions of care.

Why Improving Medication Reconciliation Is Critical to Patient Safety

“It’s critically important that clinicians have accurate and usable medication histories to help protect patients from dangerous ADEs and save time tracking down and typing in information, which can introduce errors,” said G. Cameron Deemer, president of DrFirst. “As part of our long-standing promise to help improve patient safety through technology, we are committed to working with MARQUIS to help clinicians follow best practices that improve their medication reconciliation quality.”

Medication reconciliation is a critical patient safety process. When done well, it significantly lessens the risk of adverse drug events. The process is recommended every time a patient has a transition of care, such as being admitted or discharged from a hospital. Accurate medication reconciliation is a National Patient Safety Goal of The Joint Commission.

SHM’s MARQUIS Med Rec Collaborative, which measures “unintentional medication discrepancies per patient” for quality improvement purposes, is endorsed by the National Quality Forum (NQF) and is the official Leapfrog measure for medication reconciliation.  The Collaborative is helping hospitals nationwide reduce unintentional medication discrepancies that lead to adverse drug events and patient harm. Participating hospitals identify medication reconciliation process gaps, develop and implement better ways to prescribe and document medications, and measure improvement over time.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Building on insights gained from the 2018 Multi-Center Medication Reconciliation Quality Improvement Study (MARQUIS), which demonstrated a consistent 9% reduction in medication history discrepancies per month, DrFirst will customize The Collaborative’s current toolkit. The integration illustrates how its MedHx solution—the healthcare industry’s broadest source of medication history data available, which yields faster and more accurate medication reconciliation—can be combined with best practices in medication history-taking to achieve breakthrough reductions in medication discrepancies. After the customized toolkit is distributed and implemented, the MARQUIS Collaborative will take a cohort of DrFirst hospital clients through a 14-month quality improvement program.

DrFirst also will provide hospitals and ambulatory clinicians that use its MedHx solution with evidence-based tools to prescribe, document, and reconcile medications accurately and reduce ADEs.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Amyris to Acquire Menolabs for Menopause Wellness Accelerating Growth of Consumer BusinessAmyris to Acquire Menolabs for Menopause Wellness Accelerating Growth of Consumer Business
  • Mental Health Chatbot Does Best When Acknowledging It’s Not HumanMental Health Chatbot Does Best When Acknowledging It’s Not Human
  • Vitamin K2 Market Research Report Covers Updated Data Considering Post Impact of COVID-19 on Share, Size and Future Demand 2027Vitamin K2 Market Research Report Covers Updated Data Considering Post Impact of COVID-19 on Share, Size and Future Demand 2027
  • Walmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMDWalmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMD
  • Amazon’s One Medical acquisition passes regulatory hurdle in OregonAmazon’s One Medical acquisition passes regulatory hurdle in Oregon
  • Antech Diagnostics Acquires Leading Canadian Animal Reference Laboratory, BiovetAntech Diagnostics Acquires Leading Canadian Animal Reference Laboratory, Biovet
  • Mentice to Acquire Vascular SimulationsMentice to Acquire Vascular Simulations
  • Top 4 Disruptions Healthcare Providers Should Prepare to AddressTop 4 Disruptions Healthcare Providers Should Prepare to Address

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications